ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00311753
Recruitment Status : Completed
First Posted : April 6, 2006
Last Update Posted : February 24, 2017
Sponsor:
Information provided by:
Novartis